Medtronic's Arctic Front Advance ST wins FDA approval

The newest version of Medtronic's Arctic Front cryoballoon has won approval for use in treatment of paroxysmal atrial fibrillation.

Medtronic (NYSE:MDT) said it won FDA approval for its Arctic Front Advance ST cryoablation catheter for treating atrial fibrillation, touting a 40% shorter tip than previous versions.

Food & Drug Administration (FDA), Medtronic

News Well, Cardiac Rhythm Management, CE Mark, Cryogenics, Pre-Market Approval (PMA)

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1Fbx39Q